Extramedullary hematopoiesis (EMH) results from the extension of hematopoietic tissue beyond the confines of the bones. Since the initiation of regular transfusion programs from an early age for all thalassemia major (ΤΜ) patients, EMH has not been considered a clinical issue anymore. The present study aims to record the prevalence of EMH in chronically transfused ΤΜ patients followed at our institution and to investigate possible risk factors associated with its occurrence. The project was designed as a retrospective, nonexperimental, descriptive, exploratory study. In total, the study enrolled 104 patients. EMH was revealed in 15/104 (14%) patients. The presence of intravening sequence (IVS)-I-6 was significantly related with the development of EMH (p < 0.05). No other demographic or biological factor studied was found to be related with the presence of EMH. The study stresses a profound incidence of asymptomatic EMH in a solid group of well-transfused ΤΜ patients. Given the high incidence of the IVS-I-6 allele in the Mediterranean and Middle Eastern region, high-quality, prospective, multicenter studies could confirm the association of EMH occurrence with the presence of the IVS-I-6 mutation and further evaluate the exact role of this mutation in the EMH process.

1.
Galanello R, Origa R: Beta-thalassemia. Orphanet J Rare Dis 2010;5:11.
2.
Giardine B, Borg J, Viennas E, Pavlidis C, Moradkhani K, Joly P, Bartsakoulia M, Riemer C, Miller W, Tzimas G, Wajcman H, Hardison RC, Patrinos GP: Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res 2014;42:D1063-D1069.
3.
Ribeil J-A, Arlet J-B, Dussiot M, Moura IC, Courtois G, Hermine O: Ineffective erythropoiesis in β-thalassemia. ScientificWorldJournal 2013;2013:394295.
4.
Fessas P: Inclusions of hemoglobin erythroblasts and erythrocytes of thalassemia. Blood 1963;21:21-32.
5.
Vigi V, Volpato S, Gaburro D, Conconi F, Bargellesi A, Pontremoli S: The correlation between red-cell survival and excess of alpha-globin synthesis in beta-thalassemia. Br J Haematol 1969;16:25-30.
6.
Traeger-Synodinos J, Kanavakis E, Vrettou C, Maragoudaki E, Michael T, Metaxotou-Mavromati A, Kattamis C: The triplicated alpha-globin gene locus in beta-thalassaemia heterozygotes: clinical, haematological, biosynthetic and molecular studies. Br J Haematol 1996;95:467-471.
7.
Cappellini M-D, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A: Guidelines for the Clinical Management of Thalassaemia, ed 2 revised. Nicosia, Thalassaemia International Federation, 2008.
8.
Porcaro AB, Novella G, Antoniolli SZ, Martignoni G, Brunelli M, Curti P: Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. Int Urol Nephrol 2001;33:601-603.
9.
Papavasiliou C, Gouliamos A, Andreou J: The marrow heterotopia in thalassemia. Eur J Radiol 1986;6:92-96.
10.
Dore F, Pardini S, Gaviano E, Longinotti M, Bonfigli S, Rovasio S, Tomiselli A, Cossu F: Recurrence of spinal cord compression from extramedullary hematopoiesis in thalassemia intermedia treated with low doses of radiotherapy. Am J Hematol 1993;44:148.
11.
Aydingöz U, Oto A, Cila A: Spinal cord compression due to epidural extramedullary haematopoiesis in thalassaemia: MRI. Neuroradiology 1997;39:870-872.
12.
Issaragrisil S, Piankigagum A, Wasi P: Spinal cord compression in thalassemia. Report of 12 cases and recommendations for treatment. Arch Intern Med 1981;141:1033-1036.
13.
Tan T-C, Tsao J, Cheung F-C: Extramedullary haemopoiesis in thalassemia intermedia presenting as paraplegia. J Clin Neurosci 2002;9:721-725.
14.
Dragean CA, Duquesne L, Theate I, Ghaye B, Coche EE: Extramedullary haemopoiesis and spinal cord compression. Lancet 2011;377:251.
15.
Saisorn I, Leewansangtong S, Sukpanichnant S, Ruchutrakool T, Leemanont P: Intrarenal extramedullary hematopoiesis as a renal mass in a patient with thalassemia. J Urol 2001;165:507-508.
16.
Sorcinelli R, Cacace E, Del Piano M: Optic nerve compression by extramedullary hematopoietic tissue in a patient suffering from beta-thalassemia intermedia. Metab Pediatr Syst Ophthalmol (1985) 1999-2000;22-23:5-6.
17.
Aarabi B, Haghshenas M, Rakeii V: Visual failure caused by suprasellar extramedullary hematopoiesis in beta thalassemia: case report. Neurosurgery 1998;42:922-925; discussion 925-926.
18.
Newton KL, McNeeley SG, Novick M: Extramedullary hematopoiesis presenting as a pelvic mass in a patient with beta-thalassemia intermedia. JAMA 1983;250:2178-2179.
19.
Papavasiliou C, Sandilos P: Effect of radiotherapy on symptoms due to heterotopic marrow in beta-thalassaemia. Lancet 1987;1:13-14.
20.
Ibabao J, Kassapidis S, Demetis S, Burack J, Gordon D, Choi K, Braveman AS: Bilateral pleural effusions in a beta-thalassemia intermedia patient with posterior mediastinal extramedullary hematopoietic masses. Hemoglobin 1999;23:249-253.
21.
Taher A, Skouri H, Jaber W, Kanj N: Extramedullary hematopoiesis in a patient with beta-thalassemia intermedia manifesting as symptomatic pleural effusion. Hemoglobin 2001;25:363-368.
22.
Kapelushnik J, Shalev H, Schulman H, Moser A, Tamary H: Upper airway obstruction-related sleep apnea in a child with thalassemia intermedia. J Pediatr Hematol Oncol 2001;23:525-526.
23.
Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD: Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010;115:1886-1892.
24.
Haidar R, Mhaidli H, Taher AT: Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia. Eur Spine J 2010;19:871-878.
25.
Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA: Non-transfusion-dependent thalassemias. Haematologica 2013;98:833-844.
26.
Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V, Weatherall SD: Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT). Nicosia, Thalassaemia International Federation, 2013.
27.
Pepe A, Meloni A, Briatico Vangosa A, Terrazzino F, Neri MG, Maddaloni D, Roccamo G, Armari S, Maggio A, Salvatori C, Positano V, Ricchi P: Prevalence of extramedullary hematopoiesis, vertebral, hepatic and splenic hemangioma and renal cyst among thalassaemic patients: a retrospective study from the Myocardial Iron in Thalassemia (MIOT) Network. Blood 2015;126:2154.
28.
Taher A, Isma'eel H, Cappellini MD: Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006;37:12-20.
29.
Ricchi P, Ammirabile M, Costantini S, Di Matola T, Verna R, Diano A, Foglia MC, Spasiano A, Cinque P, Prossomariti L: A useful relationship between the presence of extramedullary erythropoiesis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study. Ann Hematol 2012;91:905-909.
30.
Dore F, Cianciulli P, Rovasio S, Oggiano L, Bonfigli S, Murineddu M, Pardini S, Simonetti G, Gualdi G, Papa G: Incidence and clinical study of ectopic erythropoiesis in adult patients with thalassemia intermedia. Ann Ital Med Int 1992;7:137-140.
31.
Logothetis J, Constantoulakis M, Economidou J, Stefanis C, Hakas P, Augoustaki O, Sofroniadou K, Loewenson R, Bilek M: Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 1972;22:294-304.
32.
Prabhakar S, Chopra JS, Khosla VK, Dash S, Banerjee AK: Spinal cord compression in homozygous beta thalassaemia. Surg Neurol 1980;13:351-354.
33.
Musallam KM, Angastiniotis M, Eleftheriou A, Porter JB: Cross-talk between available guidelines for the management of patients with beta-thalassemia major. Acta Haematol 2013;130:64-73.
34.
Ricchi P, Meloni A, Spasiano A, Giovanna Neri M, Rita Gamberini M, Cuccia L, Caruso V, Gerardi C, D'Ascola DG, Rosso R, Campisi S, Rizzo M, Terrazzino F, Vangosa AB, Chiodi E, Missere M, Mangione M, Positano V, Pepe A: Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients. Am J Hematol 2015;90:1008-1012.
35.
Martina IS, van Doorn PA: Spinal cord compression due to extramedullary haematopoiesis in thalassaemia: a case report and review of the literature. J Neurol 1996;243:364-366.
36.
Knoblich R: Extramedullary hematopoiesis presenting as intrathoracic tumors. Cancer 1960;13:462-468.
37.
Lyall A: Massive extramedullary bone marrow formation in a case of pernicious anemia. J Pathol Bacteriol 1935;41:469-472.
38.
Chourmouzi D, Pistevou-Gompaki K, Plataniotis G, Skaragas G, Papadopoulos L, Drevelegas A: MRI findings of extramedullary haemopoiesis. Eur Radiol 2001;11:1803-1806.
39.
Waye JS, Eng B, Patterson M, Wasi P, Chui DH, Francombe WH, Sher GD, Olivieri NF: Severity of beta-thalassemia due to genotypes involving the IVS-I-6 (T->C) mutation. Am J Hematol 1995;50:15-19.
40.
Atanasovska B, Bozhinovski G, Plaseska-Karanfilska D, Chakalova L: Efficient detection of Mediterranean β-thalassemia mutations by multiplex single-nucleotide primer extension. PLoS One 2012;7:e48167.
41.
Tamagnini GP, Gonçalves P, Ribeiro MLS, Kaeda J, Kutlar F, Baysal E, Huisman TH: β-Thalassehia mutations in the Portuguese; high frequencies of two alleles in restricted populations. Hemoglobin 1993;17:31-40.
42.
López-Escribano H, Parera MM, Guix P, Serra JM, Gutierrez A, Balsells D, Oliva-Berini E, Castro JA, Ramon MM, Picornell A: Balearic archipelago: three islands, three beta-thalassemia population patterns. Clin Genet 2013;83:175-180.
43.
Villegas A, Ropero P, González FA, Anguita E, Espinós D: The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin 2001;25:273-283.
44.
Babameto-Laku A, Mitre A, Berisha S, Mokini V, Roko D: Molecular genetic characterization of β-thalassemia and sickle cell syndrome in the Albanian population. Balkan J Med Genet 2011;14:45-50.
45.
Dimovski A, Efremov DG, Jankovic L, Juricic D, Zisovski N, Stojanovski N, Nikolov N, Petkov GT, Reese AL, Stoming TA: Beta-thalassemia in Yugoslavia. Hemoglobin 1990;14:15-24.
46.
Efremov GD: Hemoglobinopathies in Yugoslavia: an update. Hemoglobin 1992;16:531-544.
47.
Pavlovic S, Urosevic J, Poznanic J, Perisic LJ, Petrucev B, Tosic N, Krivokapic-Dokmanovic L, Janic D, Cvorkov-Drazic M, Bunjevacki G: Molecular basis of thalassemia syndromes in Serbia and Montenegro. Acta Haematol 2005;113:175-180.
48.
Efremov GD: Thalassemias and other hemoglobinopathies in the Republic of Macedonia. Hemoglobin 2007;31:1-15.
49.
Boussiou M, Karababa P, Sinopoulou K, Tsaftaridis P, Plata E, Loutradi-Anagnostou A: The molecular heterogeneity of beta-thalassemia in Greece. Blood Cells Mol Dis 2008;40:317-319.
50.
Georgiou I, Makis A, Chaidos A, Bouba I, Hatzi E, Kranas V, Zilidis C, Bourantas KL: Distribution and frequency of beta-thalassemia mutations in northwestern and central Greece. Eur J Haematol 2003;70:75-78.
51.
Kattamis C, Hu H, Cheng G, Reese AL, Gonzalez-Redondo JM, Kutlar A, Kutlar F, Huisman TH: Molecular characterization of beta-thalassaemia in 174 Greek patients with thalassaemia major. Br J Haematol 1990;74:342-346.
52.
Papachatzopoulou A, Kourakli A, Stavrou EF, Fragou E, Vantarakis A, Patrinos GP, Athanassiadou A: Region-specific genetic heterogeneity of HBB mutation distribution in South-Western Greece. Hemoglobin 2010;34:333-342.
53.
Boudrahem-Addour N, Zidani N, Carion N, Labie D, Belhani M, Beldjord C: Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem. Hemoglobin 2009;33:24-36.
54.
Jiffri EH, Bogari N, Zidan KH, Teama S, Elhawary NA: Molecular updating of β-thalassemia mutations in the Upper Egyptian population. Hemoglobin 2010;34:538-547.
55.
Sirdah MM, Sievertsen J, Al-Yazji MS, Tarazi IS, Al-Haddad RM, Horstmann RD, Timmann C: The spectrum of β-thalassemia mutations in Gaza Strip, Palestine. Blood Cells Mol Dis 2013;50:247-251.
56.
El-Latif MA, Filon D, Rund D, Oppenheim A, Kanaan M: The beta+-IVS-I-6 (T->C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin 2002;26:33-40.
57.
Makhoul NJ, Wells RS, Kaspar H, Shbaklo H, Taher A, Chakar N, Zalloua PA: Genetic heterogeneity of beta thalassemia in Lebanon reflects historic and recent population migration. Ann Hum Genet 2005;69:55-66.
58.
Jarjour RA, Murad H, Moasses F, Al-Achkar W: Molecular update of β-thalassemia mutations in the Syrian population: identification of rare β-thalassemia mutations. Hemoglobin 2014;38:272-276.
59.
Kyriacou K, Al Quobaili F, Pavlou E, Christopoulos G, Ioannou P, Kleanthous M: Molecular characterization of beta-thalassemia in Syria. Hemoglobin 2000;24:1-13.
60.
Baysal E, Indrak K, Bozkurt G, Berkalp A, Aritkan E, Old JM, Ioannou P, Angastiniotis M, Droushiotou A, Yüregir GT, Killinç Y, Huisman TH: The beta-thalassaemia mutations in the population of Cyprus. Br J Haematol 1992;81:607-609.
61.
Aldemir O, Izmirli M, Kaya H: The spectrum of β-thalassemia mutations in Hatay, Turkey: reporting three new mutations. Hemoglobin 2014;38:325-328.
62.
Bilgen T, Arikan Y, Canatan D, Yeşilipek A, Keser I: The association between intragenic SNP haplotypes and mutations of the beta globin gene in a Turkish population. Blood Cells Mol Dis 2011;46:226-229.
63.
Mendilcioglu I, Yakut S, Keser I, Simsek M, Yesilipek A, Bagci G, Luleci G: Prenatal diagnosis of β-thalassemia and other hemoglobinopathies in southwestern Turkey. Hemoglobin 2011;35:47-55.
64.
Basak AN: The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience. Hemoglobin 2007;31:233-241.
65.
Cürük MA, Arpaci A, Attila G, Tuli A, Kilinç Y, Aksoy K, Yüregir GT: Genetic heterogeneity of beta-thalassemia at Cukurova in southern Turkey. Hemoglobin 2001;25:241-245.
66.
Abuzenadah AM, Hussein IMR, Damanhouri GA, A-Sayes FM, Gari MA, Chaudhary AG, Zaher GF, Al-Attas A, Al-Qahtani MH: Molecular basis of β-thalassemia in the western province of Saudi Arabia: identification of rare β-thalassemia mutations. Hemoglobin 2011;35:346-357.
67.
Tadmouri GO, Gulen RI: Deniz: the electronic database for beta-thalassemia mutations in the Arab world. Saudi Med J 2003;24:1192-1198.
68.
Jalal SD, Al-Allawi NAS, Bayat N, Imanian H, Najmabadi H, Faraj A: β-Thalassemia mutations in the Kurdish population of northeastern Iraq. Hemoglobin 2010;34:469-476.
69.
Al-Allawi NAS, Jubrael JMS, Hughson M: Molecular characterization of beta-thalassemia in the Dohuk region of Iraq. Hemoglobin 2006;30:479-486.
70.
Al-Allawi NAS, Jalal SD, Nerwey FF, Al-Sayan GOO, Al-Zebari SSM, Alshingaly AA, Markous RD, Jubrael JM, Hamamy H: Sickle cell disease in the Kurdish population of northern Iraq. Hemoglobin 2012;36:333-342.
71.
Al-Allawi NAS, Jalal SD, Mohammad AM, Omer SQ, Markous RSD: β-Thalassemia intermedia in Northern Iraq: a single center experience. Biomed Res Int 2014;2014:262853.
72.
Mehrabi M, Alibakhshi R, Fathollahi S, Farshchi MR: The spectrum of β-thalassemia mutations in Kermanshah Province in West Iran and its association with hematological parameters. Hemoglobin 2013;37:544-552.
73.
Neishabury M, Azarkeivan A, Oberkanins C, Esteghamat F, Amirizadeh N, Najmabadi H: Molecular mechanisms underlying thalassemia intermedia in Iran. Genet Test 2008;12:549-556.
74.
Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, Ghawidel-Parsa S, Naieni KH, Rahmani M, Babrzadeh F, Dilmaghani-Zadeh M, Farhud DD: Distribution of beta-thalassemia mutations in the northern provinces of Iran. Hemoglobin 2007;31:351-356.
75.
Ferrara M, Matarese SMR, Francese M, Borrelli B, Perrotta A, Meo A, La Rossa MA, Esposito L: Role of polymorphic sequences 5′ to the G(gamma) gene and 5′ to the beta gene on the homozygous beta thalassemic phenotype. Hemoglobin 2003;27:167-175.
76.
Danise P, Amendola G, Di Concilio R, Cillari E, Gioia M, Di Palma A, Avino D, Rigano P, Maggio A: Nucleated red blood cells and soluble transferrin receptor in thalassemia syndromes: relationship with global and ineffective erythropoiesis. Clin Chem Lab Med 2009;47:1539-1542.
77.
Karakukcu M, Karakukcu C, Unal E, Ozturk A, Ciraci Z, Patiroglu T, Ozdemir MA: The importance of nucleated red blood cells in patients with beta thalassemia major and comparison of two automated systems with manual microscopy and flow cytometry. Clin Lab 2015;61:1289-1295.
78.
Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Pepe A, Cinque P, Pagano L, Casale M, Filosa A, Prossomariti L: Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia. Blood Transfus 2014;12(suppl 1):s124-s130.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.